STOK
NASDAQ
US
Stoke Therapeutics, Inc. - Common Stock
$32.74
▲ +$0.75
(+2.34%)
Vol 564K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.8B
P/E
44.2
ROE
13.4%
Margin
20.0%
D/E
0.00
Beta
1.09
52W
$5–$39
Wall Street Consensus
18 analysts · Apr 20268
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating
Price Chart
Similar Stocks
RARE
Ultragenyx Pharmaceutical Inc
$2.2B
TYRA
Tyra Biosciences Inc
$1.4B
CLDX
Celldex Therapeutics Inc
$1.8B
AGIO
Agios Pharmaceuticals Inc
$1.6B
SLNO
Soleno Therapeutics Inc
$2.5B
VRDN
Viridian Therapeutics Inc
$3.0B
CAPR
Capricor Therapeutics Inc
$1.6B
SION
Sionna Therapeutics Inc
$1.8B
VCEL
Vericel Corp
P/E 139.2
$1.8B
Earnings
Beat rate: 60.0%
Next Report
May 11, 2026
EPS Estimate: $-0.84
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.84 | — | — |
| Dec 2025 | $-0.73 | $-0.97 | $-0.24 |
| Sep 2025 | $-0.58 | $-0.65 | $-0.07 |
| Jun 2025 | $-0.52 | $-0.40 | +$0.12 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 18.6% | 18.3% | 18.3% | 18.3% | 13.4% | 13.4% |
| P/E (TTM) | 11.61 | 20.05 | 24.50 | 31.36 | 41.40 | 44.16 |
| Net Margin | -170.0% | 26.3% | 26.3% | 26.3% | 20.0% | 20.0% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.98 | 6.98 | 6.98 | 6.98 | 6.53 | 6.53 |
Key Ratios
ROA (TTM)
11.5%
P/S (TTM)
8.82
P/B
2.6
EPS (TTM)
$0.67
CF/Share
$-2.37
52W High
$38.69
52W Low
$5.35
$5.35
52-Week Range
$38.69
How does STOK compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
STOK valuation vs Biotechnology peers
P/E ratio
44.2
▲
135%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
8.8
▼
31%
below
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.6
▲
4%
above
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
STOK profitability vs Biotechnology peers
ROE
13.4%
▲
120%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
20.0%
▲
107%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
11.5%
▲
125%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
STOK financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.5
▲
47%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.1
▲
13%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
STOK fundamentals radar
STOK
Peer median
Industry
STOK profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio